"Blume-Peytavi et al23 performed a randomized,
double-blind, placebo-controlled pilot study of
16 men with androgenetic alopecia, applying
topical latanoprost 0.1% daily on the right or left
frontotemporal mini-zones. After 24 weeks of treatment,
the latanoprost-treated site demonstrated a
significant increase in hair density compared with
baseline (P \ .001) and placebo site (P = .0004). Besides a localized erythematous reaction, no
adverse events were reported. Despite these
findings, in a case report of a woman with female
pattern hair loss treated with injected bimatoprost, a
similar response was not seen.24"
i'd say that's pretty encouraging. positive response and no adverse affects at 0.1% solution, Isn't bim using a 1-3% solution?
double-blind, placebo-controlled pilot study of
16 men with androgenetic alopecia, applying
topical latanoprost 0.1% daily on the right or left
frontotemporal mini-zones. After 24 weeks of treatment,
the latanoprost-treated site demonstrated a
significant increase in hair density compared with
baseline (P \ .001) and placebo site (P = .0004). Besides a localized erythematous reaction, no
adverse events were reported. Despite these
findings, in a case report of a woman with female
pattern hair loss treated with injected bimatoprost, a
similar response was not seen.24"
i'd say that's pretty encouraging. positive response and no adverse affects at 0.1% solution, Isn't bim using a 1-3% solution?
Comment